Sector ratings Gilead Sciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 20:00:00 13/03/2026 GMT			5-day change	1st Jan Change
144.99 ^USD	+0.42%		+0.74%	+18.13%

03-11	Gilead Sciences, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 11:00 AM
03-10	Gilead Sciences, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-10-2026 11:20 AM

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
GILEAD SCIENCES, INC.	180B		AAA
ELI LILLY AND COMPANY	873B		A
JOHNSON & JOHNSON	583B		BBB
ABBVIE INC.	398B		AA
ROCHE HOLDING AG	324B		AA
ASTRAZENECA PLC	297B		A
NOVARTIS AG	294B		AAA
MERCK & CO., INC.	287B		A
AMGEN INC.	198B		A
PFIZER INC.	153B		BBB
VERTEX PHARMACEUTICALS INCORPORATED	121B		AA
BRISTOL-MYERS SQUIBB COMPANY	120B		A
GSK PLC	109B		AA
SANOFI	107B		A
CHUGAI PHARMACEUTICAL CO., LTD.	97.45B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	56.2B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	53.38B		AA
BAYER AG	44.31B		AA
HALEON PLC	44.37B		AA
Average	220.21B		AA
Weighted average by Cap.			AA